Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone（UNIGUIDE-1）
Clinical trial NCT07659574 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07659574
- Sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2027-09-24
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.